Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The effect of femoral head size on edge loading in metal-on-metal hip joint replacement under dynamic separation conditions.

Liu F, Lian C, Feng L, Wang J, Du W.

J Biomed Mater Res B Appl Biomater. 2019 Nov 30. doi: 10.1002/jbm.b.34531. [Epub ahead of print]

PMID:
31785080
2.

Modified Singular Spectrum Decomposition and Its Application to Composite Fault Diagnosis of Gearboxes.

Wang J, Han X, Wang Z, Du W, Zhou J, Zhang J, He H, Guo X.

Sensors (Basel). 2018 Dec 24;19(1). pii: E62. doi: 10.3390/s19010062.

3.

Application of Improved Singular Spectrum Decomposition Method for Composite Fault Diagnosis of Gear Boxes.

Du W, Zhou J, Wang Z, Li R, Wang J.

Sensors (Basel). 2018 Nov 6;18(11). pii: E3804. doi: 10.3390/s18113804.

4.

Research on Fault Diagnosis of Gearbox with Improved Variational Mode Decomposition.

Wang Z, Wang J, Du W.

Sensors (Basel). 2018 Oct 18;18(10). pii: E3510. doi: 10.3390/s18103510.

5.

Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial.

Qin S, Li J, Wang L, Xu J, Cheng Y, Bai Y, Li W, Xu N, Lin LZ, Wu Q, Li Y, Yang J, Pan H, Ouyang X, Qiu W, Wu K, Xiong J, Dai G, Liang H, Hu C, Zhang J, Tao M, Yao Q, Wang J, Chen J, Eggleton SP, Liu T.

J Clin Oncol. 2018 Oct 20;36(30):3031-3039. doi: 10.1200/JCO.2018.78.3183. Epub 2018 Sep 10.

6.

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Study.

Xiong L, Li R, Sun J, Lou Y, Zhang W, Bai H, Wang H, Shen J, Jing B, Shi C, Zhong H, Gu A, Jiang L, Shi J, Fang W, Zhao H, Zhang J, Wang J, Ye J, Han B.

Oncologist. 2019 Feb;24(2):157-e64. doi: 10.1634/theoncologist.2018-0120. Epub 2018 Aug 29.

7.

A computational parametric study on edge loading in ceramic-on-ceramic total hip joint replacements.

Liu F, Feng L, Wang J.

J Mech Behav Biomed Mater. 2018 Jul;83:135-142. doi: 10.1016/j.jmbbm.2018.04.018. Epub 2018 Apr 22.

PMID:
29704828
8.

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect.

Guimarães PO, Lopes RD, Wojdyla DM, Abdul-Rahim AH, Connolly SJ, Flaker GC, Wang J, Hanna M, Granger CB, Wallentin L, Lees KR, Alexander JH, McMurray JJV.

Cardiovasc Drugs Ther. 2017 Jun;31(3):295-301. doi: 10.1007/s10557-017-6728-z.

PMID:
28516318
9.

Meta-analysis framework for exact inferences with application to the analysis of rare events.

Yang G, Liu D, Wang J, Xie MG.

Biometrics. 2016 Dec;72(4):1378-1386. doi: 10.1111/biom.12497. Epub 2016 Feb 22.

PMID:
26909752
10.

Is magnetic resonance/ultrasound fusion prostate biopsy better than systematic prostate biopsy? An updated meta- and trial sequential analysis.

Wu J, Ji A, Xie B, Wang X, Zhu Y, Wang J, Yu Y, Zheng X, Liu B, Xie L.

Oncotarget. 2015 Dec 22;6(41):43571-80. doi: 10.18632/oncotarget.6201.

11.

Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.

Granger CB, Lopes RD, Hanna M, Ansell J, Hylek EM, Alexander JH, Thomas L, Wang J, Bahit MC, Verheugt F, Lawrence J, Xavier D, Wallentin L.

Am Heart J. 2015 Jan;169(1):25-30. doi: 10.1016/j.ahj.2014.09.006. Epub 2014 Sep 28. Erratum in: Am Heart J. 2015 Apr;169(4):594.

PMID:
25497244
12.

Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE Trial.

Alexander JH, Levy E, Lawrence J, Hanna M, Waclawski AP, Wang J, Califf RM, Wallentin L, Granger CB.

Am Heart J. 2013 Sep;166(3):559-65. doi: 10.1016/j.ahj.2013.05.025. Epub 2013 Aug 15.

PMID:
24016507
13.

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib.

Cortes JE, Kantarjian HM, Brümmendorf TH, Kim DW, Turkina AG, Shen ZX, Pasquini R, Khoury HJ, Arkin S, Volkert A, Besson N, Abbas R, Wang J, Leip E, Gambacorti-Passerini C.

Blood. 2011 Oct 27;118(17):4567-76. doi: 10.1182/blood-2011-05-355594. Epub 2011 Aug 24. Erratum in: Blood. 2013 Oct 3;122(14):2524.

14.

Evaluation of the quality of investigative centers using clinical ratings and compliance data.

Sun J, Wang J, Liu G.

Contemp Clin Trials. 2008 Mar;29(2):252-8. Epub 2007 Sep 21.

PMID:
17931983
15.

Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials.

Liu GF, Wang J, Liu K, Snavely DB.

Stat Med. 2006 Apr 30;25(8):1275-86.

PMID:
16138360

Supplemental Content

Loading ...
Support Center